Researchers have found that a new vaccine for malaria may be more than 70% effective on children in a phase II clinical trial in Burkina Faso. No other vaccine comes close to that. The public health impacts could be far-reaching if the results continue in further trials, Halidou Tinto tells host Marco Werman. He is a professor of parasitology and principal investigator at the Clinical Research Unit of Nanoro, in Burkina Faso.
The story you just read is not locked behind a paywall because listeners and readers like you generously support our nonprofit newsroom. Now more than ever, we need your help to support our global reporting work and power the future of The World. Can we count on you?